Intervention Group: Clinical Trials

7 trials of Intervention Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown. 7 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Recruiting 2, Unknown 2
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 11Unknown 1

Follow Intervention Group: new trials by email Literature Review of Intervention Group trials Research Report on Intervention Group

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Further MT for Antibiotic-Resistant Bacterial Colonization
Microbiome Therapeutic, Placebo - Intestinal Multi-drug Resistant Organism Colonization
Phase 2RecruitingEmory University402024-04-252026-05-06
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Caffeine citrate, Placebo - Prematurity, Respiratory Disease
Phase 2 / Phase 3RecruitingMinistry of Health, Saudi Arabia1342023-10-122025-06-27
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
bevacizumab with oral curcumin, bevacizumab with oral placebo - Diabetic Macular Edema, Macular Edema
Phase 2 / Phase 3UnknownIsfahan University of Medical Sciences522021-10-102024-09-19
Intranasal Ketamine as a Sedative for Venipuncture
Ketamine, Placebo - Respiratory Tract Disease, Acute Pain
Phase 2 / Phase 3CompletedHospital de Clinicas de Porto Alegre392015-04-012016-10-11
Impact of an Integrated Intervention on Mental Health in Survivors of Intimate Partner Violence
Intervention Group - Domestic Violence
Phase 2CompletedMacmillan Research Group UK1202013-10-012015-09-29
Mom Power is an Attachment Based Parenting Program for Families and Their Children
Mom Power Intervention Group, Mom Power Attentional Control Group - Parenting
Phase 2CompletedUniversity of Michigan4192011-09-012016-04-01
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia
human umbilical cord mesenchymal stem cells - Hereditary Ataxia
Phase 1 / Phase 2UnknownShenzhen Beike Bio-Technology Co., Ltd.202010-01-012012-11-28

Conditions studied

Acute Pain (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Child Behavior (1)  ·  Diabetic Retinopathy (1)  ·  Digestive System Diseases (1)  ·  Macular Edema (1)  ·  Premature Birth (1)  ·  Pseudomonas Infections (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Retinal Neovascularization (1)  ·  Spinocerebellar Degenerations (1)

Sponsors

Emory University (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Isfahan University of Medical Sciences (1)  ·  Macmillan Research Group UK (1)  ·  Ministry of Health, Saudi Arabia (1)  ·  Shenzhen Beike Bio-Technology Co., Ltd. (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  China (1)  ·  India (1)  ·  Iran (1)  ·  Saudi Arabia (1)

Top investigators

Bharat Chaudhari, MA (1)  ·  Jefferson Piva (1)  ·  Maria Muzik, MD (1)  ·  Michael Woodworth, MD, MSc (1)  ·  Nehad Nasef (1)

Results publications

PMID 23151076, PMID 28647759, PMID 37732075

NIH funding

U54CK000601 (1)